A topical and innovative area in the local food industry is the development of breast-milk substitutes enriched with lactoferrin. Objective. To study the clinical efficacy of adapted milk formula based on the carbohydrate and protein component (SDS-90) enriched with lactoferrin in children aged 0 to 6 months. Patients and methods. This open-label, single-center, prospective clinical study evaluated the clinical efficacy and tolerability of adapted milk formula based on the carbohydrate and protein component (SDS-90) enriched with lactoferrin in 20 children (median age 2.65 [1.5; 3.5] months). The criterion for efficacy was the dynamics of anthropometric parameters, and the criterion for tolerability was the dynamics of skin and gastrointestinal symptoms (regurgitation, flatulence, frequency and nature of stools). These symptoms were assessed at the beginning of the study and after 1 month. Results. During the observation period, the median increase in height was 2.5 [2.0; 3.0] cm and in body weight – 775 [650; 825] g, which indicates optimal rates of physical development. At the time of inclusion in the study, dry skin was recorded in 2 (10%) children, acne in 1 (5%) child, and after 1 month of receiving the formula, all children had clear skin. Functional regurgitation at the time of transfer to the study formula was diagnosed in 7 (35%) children (single volume – 10–20 mL), at the end of the study it persisted in only 2 (10%) children, with a frequency of 2–3 times per day (single volume – up to 10 mL). At baseline, flatulence was observed in 8 (40%) children, colic in 10 (50%), frequent stools (6–8 times per day) in 10 (50%), and constipation (no stools for >48 hours) in 4 (20%). After 1 month of receiving the formula, flatulence and colic were not observed in any of the children, and the frequency of stools decreased to 1–3 times per day in 12 (60%) children and to 4–6 times per day in 8 (40%) children. Conclusion. The results demonstrate the feasibility of enriching breast-milk substitutes with lactoferrin, a biologically active multifunctional glycoprotein isolated from cow’s colostrum. Key words: artificial feeding, cow’s milk protein, adapted milk formula, lactoferrin, secretory IgA, mucosal immunity, serum iron, ferritin, functional gastrointestinal disorders, gastrointestinal symptoms